ABSTRACT a-Catenins are actin-filament binding proteins and critical subunits of the cadherin-catenin cell-cell adhesive complex. They are found in nominally-defined epithelial (E), neural (N), and testis (T) forms transcribed from three distinct genes. While most of a-catenin research has focused on the developmentally essential founding member, aE-catenin, this review discusses recent studies on aT-catenin (CTNNA3), a developmentally dispensable isoform that is emerging as relevant to cardiac, allergic and neurological diseases.
Introduction
The cadherin-catenin complex is widely viewed as a linchpin of tissue cohesion and organization. This complex contains a transmembrane cadherin extracellular domain that engages an identical cadherin on adjacent cells. The cadherin cytoplasmic domain associates with catenins that either stabilize cell surface cadherins (e.g., p120 ctn ) or physically links cadherins to the underlying cytoskeleton (e.g., b-catenin and a-catenin to actin filaments; p120 ctn to microtubules) to bring about robust intercellular adhesion. 1, 2 For historical reasons, the most well studied cadherin-catenin complex comprises cadherin and catenins typically found in epithelia across tissue types-an Epithelial-cadherin (E-cadherin), paired with the more ubiquitously expressed p120 ctn , b-catenin and "epithelial" a-catenin (aE-catenin, or aE-cat). This "canonical" cadherin-catenin complex, however, belies known gene complexity at each protein position in the cadherin-catenin complex (Fig. 1) . Although fundamental paradigms of cell-cell adhesion have been gleaned from this canonical cadherin-catenin complex, expansion of the cadherin-catenin gene family evolved for a reason-enabling cell and tissue specialization of the basic epithelial adhesive paradigm, which favors organismal fitness. In this review, we focus on one of the more recently evolved catenins, aT-catenin (aT-cat), as a means to understand how modest alterations in the cadherin-catenin adhesion system may be relevant to a range of human diseases. a-Catenins: Knock-out phenotypes reflect tissue distribution a-Catenins are b-catenin and actin-binding proteins, where binding to both b-catenin and actin is required to directly link the cadherin complex to cortical actin filaments. They are found in nominally-defined epithelial (E), neural (N), and testis (T) forms transcribed from three distinct genes, 3 where each is sufficient to rescue cadherin-based adhesion in a-catenin-negative cell lines. [3] [4] [5] [6] As is often the case with early nomenclature, formal names can be misleading now that greater resolving RNA sequencing technologies are available. In this regard, the human genotype-tissue expression (GTEx) database 7 clearly shows that aE-cat (CTNNA1) is not epithelial-restricted, but rather ubiquitously expressed (Fig. 2a) . These data are consistent with evidence that mouse knock-outs targeting Ctnna1 across a range of tissues can lead to penetrant loss of cell-cell adhesion/tissue organization (e.g., whole embryo, 8 skin, 9 brain 10 and heart 11 ). In contrast to the ubiquity of aE-cat, aN-cat (CTNNA2) is largely restricted to brain (Fig. 2b) , consistent with evidence that Ctnna2 knock-out mice display hypomorphic brains and perinatal lethality. 12, 13 Remarkably, the more recently evolved aT-cat (CTNNA3), named after its expression in the testis and best known for its role in the heart, 14 is also abundantly expressed in the brain, spinal cord, and peripheral nerve (Fig. 2c) . Although Ctnna3 knock-out mice are viable and fertile, 15 this curious tissue distribution of CTNNA3, together with growing linkages between CTNNA3 and diseases compatible with this distribution (see below), raise the intriguing notion that aT-cat/CTNNA3 may be the a-catenin most relevant to a broad range of human diseases.
aE-cat:
Founding member of the a-catenin family Due to its ubiquity, molecular and structural analyses are best known for aE-cat, the subject of recent excellent reviews. [16] [17] [18] 19, 20 The prevailing view of aE-cat in the cadherin complex is as a mechanosensitive scaffold protein that features a series of six, bundled a-helical domain-regions. [21] [22] [23] [24] [25] There are two key aspects to its mechanosensitivity. First, the C-terminal F-actin binding domain of aE-cat shows preferential binding to actin filaments under tension in vitro, 26 suggesting that aE-cat may preferentially couple the cadherin/ b-catenin complex to actin filaments that are under myosin-based cortical tension. Contractile actin structures are typically found at discreet plasma membrane locations (e.g., zonula and focal adhesions), and the precise nature of this force-activated binding event is presently unclear. Second, the middle or M-region of aE-cat undergoes force-dependent unfurling, 23, 27 exposing a cryptic site that favors recruitment of the related actin-binding protein, vinculin. In epithelia, vinculin recruitment to aE-cat occurs in regions of the plasma membrane that are under elevated forces, such as an apical adhesive zone known as the zonula adherens. 23, 24 Since a number of proteins interact with aEcat through its mechanosensitive M-region, 17, 28 it is possible that some of these partners may be variably recruited to aEcat under distinct force-activated thresholds (Fig. 3) .
Given the level of amino acid identity/similarity between aE-cat and aT-cat (56.1%/73.7%) or aN-cat (76.5%/83.1%) [3] , we may reason that these related a-catenins share an analogous mechanosensitivity. Although biochemical and cellular characterization of aN-cat and aT-cat lags behind aE-cat, recent studies suggest that cadherin complexes containing these a-catenins are indeed different. For example, aE-cat recruits vinculin to adherens junctions more effectively than aN-cat using an a-catenin negative epithelial cell line, possibly due aE-cat's higher affinity for actin filaments in vitro. 24 How such differences are leveraged by epithelia (aE-cat) and neurons (aN-cat) to suit their respective junction-coupling needs Figure 1 . Schematic representation of cadherin-catenin complexes with distinct a-catenin isoforms aE-cat, aN-cat and aT-cat. Note that there is substantial isoform diversity at the other positions in the cadherin-catenin complex, such as »19 classical cadherins (i.e., catenin-binding) encompassing both type I and type II forms, 91 three p120ctns as well as the b-catenin homologue, plakoglobin (reviewed in 92 ). For simplicity, these other isoforms are not shown with the exception of aE-cat participating in an E-cadherin complex, and aT-cat with an N-cadherin complex. remains to be clarified. Moreover, in contrast to the established allosteric behavior of aE-cat, where b-catenin binding curiously limits aE-cat's capacity to bind actin filaments in solution, 29, 30 aT-cat can bind cadherin/b-catenin and actin filaments, simultaneously. 31 Thus, while aE-cat within the cadherin/b-catenin complex shows preferential binding to actin filaments under tension, 26 aT-cat behaves as a constitutively active, actin-binding protein that can physically couple cadherin/b-catenin to actin in the absence of tension, 31 which may be relevant to aT-cat's unique junctional and tissue-specific role (see below). In addition to differences in actin-binding between aE-and aT-cat proteins, recruitment of ligand-binding partners through the M-domain also appears distinct, as loss of aE-cat in heart reduces vinculin recruitment to cardiac cell-cell junctions, 11 whereas loss of aT-cat reduces plakophilin-2 (PKP2) recruitment 15, 32 (also below). Lastly, it is worth noting that all three a-catenins show a capacity to form homodimers in vitro that are incompatible with cadherin/b-catenin binding, and which allows for robust F-actin binding and bundling activity. 30, 31, 33, 34 However, recently measured kinetic parameters suggest that only aE-cat may be able to sustain the homodimeric state at physiological concentration in cells, 33 where homodimerization contributes to membrane protrusive activities required for cell migration and nascent contact formation. 35, 36 Together, these data suggest that mechanosensor, Mdomain-binding-partner and homodimerization abilities of aT-cat are distinct from aE-cat, which may be relevant to the tissue-restricted functions of aT-cat.
aT-cat in the heart and cardiomyopathy aT-cat was named for its localization in peritubular myoid cells of the testis, 32 but is currently best known for its role in the heart. This is largely because aT-cat null mice show no obvious fertility defects, but rather develop a dilated cardiomyopathy (DCM) after 3-6 months of age. 15 Although mutations in aT-cat have not yet been found associated with DCM in humans, 37, 38 two mutations (detailed below) have been implicated in the development of arrythmogenic right ventricle cardiomyopathy (ARVC). 39 As recent evidence indicates that the left ventricle is often affected in historically defined ARVC patients, this biventricular disease is now referred to as arrhythmogenic cardiomyopathy (ACM). 40 ACM disease is typically caused by mutations in proteins that comprise desmosomes, a type of cadherin-based intercellular adhesion that employs plaque proteins (plakoglobin, plakophilins, desmoplakin) to link to the intermediate filament cytoskeleton. Desmosomes are particularly important in tissues that withstand substantial mechanical strain, such as heart and skin. 42, 43 In this regard, aT-cat prominently localizes to a specialized cell-cell junction in cardiomyocytes, known as the intercalated disc (ICD), which contains distinct adherens junction, desmosome and gap junction structures. 44, 45 In the hearts of higher vertebrates, the ICD largely comprises a hybrid adherens junction/desmosome structure known as the area composita, 46, 47 where this hybrid junction is considered optimized to withstand the increased mechanical load of the four-chamber mammalian heart. [48] [49] [50] Although the unique strength and molecular mechanics of this junction type remains poorly understood, aT-cat may be a key integrator of the area composita, as it directly binds the desmosome component plakophilin-2 (PKP2) 51 while also participating in the cadherin/b-catenin complex, presumably reinforcing adherens junction and desmosome alignment (Fig. 4) . Indeed, while aT-cat knock-out hearts develop normally due to compensation by the related aE-cat, over time, these mice show reduced localization of PKP2 and the Connexin 43 gap junction component at intercalated disks. 15 Reduced area composita, hybridjunction coupling (via PKP2) likely contributes to the decreased cardiac contractility and ejection fraction of aT-cat null mice, whereas reduced gap junction coupling (via Connexin 43) increases sensitivity to ventricular arrhythmia following ischemic injury. 15 Evidence that PKP2 mutations are also associated with ACM, 52 suggest that a particular aspect of aTcat/PKP2 coupling may be important for normal right ventricle structure and function. For example, PKP2 interacts with aT-cat (but not aE-cat) via the Mdomain. 39, 51 As discussed above, both aE-cat M-and actin-binding domains require force-dependent conformation regulatory events for their respective binding activities, whereas aT-cat appears less mechanosensitive, being more available to its binding-partners. 20, 31 These or other differences may explain why aT-cat is dispensable for normal heart development (due to compensation by aE-cat), but important for cardiac function with age. Indeed, as the mechanical load on the heart increases after birth and the ICD matures, aT-cat's role as molecular integrator of the area composita appears critical, as evidenced by the earlier onset of cardiomyopathy in aT-cat mutant mice compared to aE-cat conditional KO mice (3 versus 8 months of age, respectively). 11, 15 Recent biochemical and cell culture studies now rationalize how aT-cat heterozygous mutations may function as dominant inhibitors of cardiomyocyte function in ACM: One mutation (V94D) blocks b-catenin binding 39 and favors aT-cat homodimerzation, 31 leading to altered junctional localization in cardiomyocyte junctions 31 ; the second mutation deletes a leucine in the critical actinbinding domain (L765del) and induces protein dimerization/ aggregation. 31, 39 Although formal evidence for these mutations causing ACM awaits testing in mouse models, it appears that both aT-cat pathogenic mutations enhance the intrinsic homodimerization and/or aggregation potential of aT-cat, which may prevent normal cadherin/catenin/actin coupling and other possible maladaptation. Lastly, it is worth noting that requirement of a-cateninbased cell-cell adhesion to heart structure and function is not absolute, but contextual, and based on developmental timing or degree of tissue injury. For example, the early loss of both aE-and aT-cat in mice is incompatible with heart development but tolerated when induced perinatally. 53 Remarkably, the loss of both catenins appears beneficial when removed in adult hearts subjected to ischemic injury, in part due to elevated YAP signaling that favors proliferation. 53 Such complexities raise the counterintuitive possibility that attenuating the function of proteins collectively required for tissue development may be beneficial during adult tissue repair after injury.
aT-cat linkages to allergic disease
One of the more surprising developments in the a-catenin field are the number of independent genetic association studies linking aT-cat (CTNNA3) with asthma and food allergy. Genome-wide association studies have linked several non-coding CTNNA3 polymorphisms with two distinct forms of asthma, occupational asthma induced by chemical exposure 54, 55 and steroid resistant atopic asthma. 56, 57 One study identified copy number deletions in CTNNA3 associated with pediatric food allergy. 58 The surprise with these associations is that the restricted distribution of aTcat expression in human tissues (Fig. 2, brain/peripheral nerve, heart, skeletal muscle and testis) suggests that either rare, contextually activated or non-canonical cell-types contribute to allergic disease.
Using the viable and fertile aT-cat knock-out mouse described above, our team has validated these aT-cat linkages to asthma using both chemical and house dust-mite models of asthma. 59, 60 Curiously, full loss of aT-cat strongly suppresses airway hyperreactivity, a hallmark of asthma, but the aT-cat-expressing cell type that drives allergic airway responses remains to be determined. Remarkably, the only lung cells that obviously express aT-cat are cardiomyocytes that line the pulmonary vasculature. 60, 61 However, anatomical differences in human versus rodent pulmonary veins, their proximity to airways and relative degree of cardiomyocyte ensheathment has raised doubt that cardiomyocytes are the aT-cat-expressing cell type that drives asthma. 61, 62 An appealing cell-type to consider for linkages between an adhesion protein and allergic diseases are immune cells. Although low levels of aT-cat RNA have been detected in EBV-transformed peripheral blood cells and lymphoid cancer lines 54, 56, 58 (https://www.proteinatlas. org/ENSG00000183230-CTNNA3/cell), evidence for protein detection is generally lacking, with exception of one study suggesting that aT-cat may contribute to the upregulation of basophil-activation markers, CD203c and CD63. 58 Indeed, immune cells generally do not express cadherins or a-catenin adhesion components, but Th2-cytokines can robustly upregulate E-cadherin and aE-cat in dendritic cells and alternatively activated macrophages. [63] [64] [65] [66] [67] We find no evidence that aT-cat is upregulated under these same conditions (not shown). Thus, future work will be required to further validate and understand these intriguing connections between aT-cat and allergic disease. aT-cat in the nervous system and disease Early studies documented aT-cat protein expression in brain, 3 but functional significance of this expression has lagged presumably because of difficulties interrogating behavioral defects in mice. Moreover, identification of aT-cat-expressing cell types in the brain has been somewhat limited by the lack of robust tools (e.g., fluorescent membrane-anchored reporter mouse). For example, while an early study suggested that aT-cat protein may be expressed in murine cortical neurons, 68 aT-cat is more prominently detected in ependymal cell junctions that line ventricles, as well as cells within the molecular layer of the cerebellum. 69 In human tissue, RNA sequencing data reveal that aT-cat expression is highest in brain and spinal cord (Fig. 2) , the latter of which is likely due to the presence of a central canal lined by aT-cat-positive ependymal cells. The unique functional role of aT-cat in this specialized epithelium remains unclear, however, as aT-cat knock-out mice show no obvious defect in ventricle structure, possibly due to compensatory upregulation of aE-cat.
69
Despite the absence of an obvious neurological phenotype in aT-cat null mice (Frans Van Roy, personal communication), a number of linkage studies raise the possibility that aT-cat may contribute to disease in humans. Specifically, the aT-cat gene, CTNNA3, is located near a common fragile site on chromosome 10, 70 and has been linked to late onset Alzheimer's disease in females 71 (reviewed in 72 ). CTNNA3 is also linked to autism in two large cohorts of European ancestry with replication in two other cohorts, 73 and rare deletions in aT-cat were identified in individuals with autism spectrum disorder. 74, 75 While transcriptomic analysis of WT and aT-cat knock-mouse cerebella suggest alteration of pathways linked to Alzheimer's and autism, 69 future work will be required to define the cell type and unique junctional-specialization supported by aT-cat function. Indeed, available online transcriptomic datasets of human and mouse brain cell populations suggest that oligodendrocytes may be a major aT-cat-expressing cell type in brain. 76 aT-cat associations with cancer Among the a-catenin family members, aE-cat is best appreciated for playing a contributing role in tumorigenesis in large part because it plays an integral part in epithelial cell-cell adhesion with E-cadherin (CDH1), a bona fide tumor-suppressor gene. 77, 78 Since aT-cat mRNA and protein are generally absent from epithelial tissues ( Fig. 2 ; see also Human Atlas), there was an early expectation that it might not contribute to cancer. However, a number of recent studies suggest that we may need to keep an open mind on this front. For example, a recent proximity proteomics study revealed aT-cat as the 9 th most abundant protein at E-cadherin contacts in non-transformed Madin Darby Canine Kidney epithelial cells, 79 raising the possibility that low levels of aT-cat mRNA may be uncorrelated from its polypeptide abundance. Remarkably, CTNNA3 is one of the largest genes in the genome (i.e., spanning 1.78 Megabases) and proximal to a common fragile site (FRAD10D). 80 In this regard, monoallelic or reduced expression of CTNNA3 is associated with urothelial carcinoma of the bladder, 81 pancreatic cancer associated with SchwachmanDiamond Syndrome, 82 oropharyngeal squamous cell carcinoma 83 and hepatocellular carcinoma. 84 In addition, deletion, truncation and missense mutations were identified in CTNNA3 in NSCLCs 85 and laryngeal carcinoma. 86 In some of these studies, aT-cat was knocked-down and phenotypes typically associated with cancer were modestly enhanced (e.g., proliferation, invasion, migration). 84, 86 Intriguingly, SNPs in CTNNA3 were associated with radiation induced brain cancers 87 and focal loss of CTNNA3 was associated with a hybrid neurofibroma/ schwannoma, 88 perhaps consistent with the prominent expression of CTNNA3 in brain and peripheral nerve (Fig. 2) . While these studies are suggestive, future work that makes use of validated, isoform-specific aT-cat antibodies and aT-cat knock-out/floxed mice 15, 53 will be required to determine the extent to which aT-cat is a bona fide tumor suppressor protein, particularly since the relationship between cell-cell adhesion and cancer is not universally suppressive. 89 
Revised evolutionary perspective
Comparison of the three a-catenin genes reveals that aT-cat is the most recently evolved, likely arising from an amniote-specific duplication of the aN-cat gene. 90 Evidence that aT-cat emerged with the development of terrestrial vertebrates that have a four-chambered heart, together with it being linked to ACM disease and required for normal cardiac function during murine lifespan, has led to the notion that aT-cat evolved to address the unique mechanical demands of the heart. 15, 31, 39 However, recent transcriptomic studies reveal that aT-cat is also abundantly expressed in the nervous system (Fig. 2) . 76 This not only strengthens the plausibility of recent genetic linkages between aT-cat and neurological diseases, [69] [70] [71] [72] [73] [74] [75] [76] but suggests that aT-cat evolved to meet the demands of two very different tissue systems (i.e., brain/peripheral nerves and heart). The mechano-organizational features that aT-cat uniquely brings to adherens junctions across these systems will require further study. Thus, while most of a-catenin research has focused on the developmentally essential founding member, aE-cat, the developmentally dispensable aT-cat may be worthy of greater attention, emerging as a broadly diseaserelevant a-catenin.
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